Alzheimer’s disease cortical morphological phenotypes are associated with TOMM40′523-APOE haplotypes
暂无分享,去创建一个
R. Honea | E. Vidoni | Jennie M. Burns | Rebecca J. Lepping | J. Morris | R. Swerdlow | Amber Watts | Suzanne Hunt | Elias K. Michaelis
[1] A. Kulminski,et al. Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer’s disease biomarkers , 2022, Aging.
[2] W. Lieb,et al. Long-Lived Individuals Show a Lower Burden of Variants Predisposing to Age-Related Diseases and a Higher Polygenic Longevity Score , 2022, International journal of molecular sciences.
[3] Sterling C. Johnson,et al. Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan. , 2022, Brain : a journal of neurology.
[4] Maria-Eleni Dounavi,et al. Fractal dimension of the brain in neurodegenerative disease and dementia: A systematic review , 2022, Ageing Research Reviews.
[5] A. Saykin,et al. Integrative analysis of eQTL and GWAS summary statistics reveals transcriptomic alteration in Alzheimer brains , 2022, BMC Medical Genomics.
[6] H. Arboleda,et al. Genetic Variants and Haplotypes of TOMM40, APOE, and APOC1 are Related to the Age of Onset of Late-onset Alzheimer Disease in a Colombian Population , 2022, Alzheimer disease and associated disorders.
[7] A. Saykin,et al. Integrative analysis of eQTL and GWAS summary statistics reveals novel genes related to Alzheimer's disease , 2021, Alzheimer's & Dementia.
[8] A. Kulminski,et al. Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk , 2021, Neurobiology of Aging.
[9] F. Mastaglia,et al. TOMM40‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease , 2021, NPJ Parkinson's disease.
[10] Fractal Dimension , 2020, Modern Classical Mechanics.
[11] M. Giannelli,et al. Toward a more reliable characterization of fractal properties of the cerebral cortex of healthy subjects during the lifespan , 2020, Scientific Reports.
[12] D. Cook,et al. Collective effects of age, sex, genotype, and cognitive status on fitness outcomes , 2020, Alzheimer's & dementia.
[13] Hua-jun Chen,et al. Brain Cortical Complexity Alteration in Amyotrophic Lateral Sclerosis: A Preliminary Fractal Dimensionality Study , 2020, BioMed research international.
[14] P. Sachdev,et al. Differential longitudinal changes in structural complexity and volumetric measures in community-dwelling older individuals , 2020, Neurobiology of Aging.
[15] J. Lambert,et al. Genetics of Alzheimer’s disease: where we are, and where we are going , 2019, Current Opinion in Neurobiology.
[16] J. O'Brien,et al. Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer’s Disease and Frontotemporal Dementia , 2019, Journal of Alzheimer's disease : JAD.
[17] R. Swerdlow,et al. TOMM40 '523 Associations with Baseline and Longitudinal Cognition in APOE ɛ3 Homozygotes. , 2019, Journal of Alzheimer's disease : JAD.
[18] Nick C Fox,et al. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.
[19] C. E. Han,et al. Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer’s dementia , 2019, PloS one.
[20] G. Bu,et al. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies , 2019, Nature Reviews Neurology.
[21] Paul A. Harris,et al. The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.
[22] G. Small,et al. Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding , 2018, PloS one.
[23] J. Whitwell,et al. Alzheimer's disease neuroimaging , 2018, Current opinion in neurology.
[24] O. Chiba-Falek,et al. The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes , 2018, Alzheimer's & Dementia.
[25] R. Marioni,et al. GWAS on family history of Alzheimer’s disease , 2018, bioRxiv.
[26] S. Yano,et al. Differential Effects of the Factor Structure of the Wechsler Memory Scale-Revised on the Cortical Thickness and Complexity of Patients Aged Over 75 Years in a Memory Clinic Setting , 2017, Front. Aging Neurosci..
[27] D. Bennett,et al. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline , 2017, Alzheimer's & Dementia.
[28] Sterling C. Johnson,et al. Family history and TOMM40 ‘523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts , 2017, Alzheimer's & Dementia.
[29] Jorge Sepulcre,et al. Complexity analysis of cortical surface detects changes in future Alzheimer's disease converters , 2017, Human brain mapping.
[30] A. Roses,et al. APOE ε4-TOMM40 ‘523 haplotypes and the risk of Alzheimer’s disease in older Caucasian and African Americans , 2017, PloS one.
[31] Theresa M. Harrison,et al. Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant , 2017, Alzheimer's & Dementia.
[32] R. Swerdlow,et al. Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients , 2017, Redox biology.
[33] M. Mallar Chakravarty,et al. Subcortical Shape Changes, Hippocampal Atrophy and Cortical Thinning in Future Alzheimer's Disease Patients , 2017, Frontiers in aging neuroscience.
[34] Jonathan D Mahnken,et al. Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial , 2017, PloS one.
[35] Christopher R. Madan,et al. Cortical complexity as a measure of age-related brain atrophy , 2016, NeuroImage.
[36] J. Quinn,et al. A TOMM40 poly-T variant modulates gene expression and is associated with vocabulary ability and decline in nonpathologic aging , 2016, Neurobiology of Aging.
[37] I. Deary,et al. APOE/TOMM 40 genetic loci, white matter hyperintensities, and cerebral microbleeds , 2015, International journal of stroke : official journal of the International Stroke Society.
[38] J. Donnelly,et al. Dose-Response of Aerobic Exercise on Cognition: A Community-Based, Pilot Randomized Controlled Trial , 2015, PloS one.
[39] I. Deary,et al. Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity? , 2014, Translational Psychiatry.
[40] A. Roses,et al. The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes , 2014, European Neuropsychopharmacology.
[41] Joanna M. Wardlaw,et al. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936 , 2014, Neurobiology of Aging.
[42] I. Deary,et al. Alzheimer’s Disease Susceptibility Genes APOE and TOMM40, and Hippocampal Volumes in the Lothian Birth Cohort 1936 , 2013, PloS one.
[43] Mark T. W. Ebbert,et al. Genetics of Alzheimer's Disease , 2013, BioMed Research International.
[44] G. Alexander,et al. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. , 2013, JAMA neurology.
[45] Jong-Min Lee,et al. Automated Sulcal Depth Measurement on Cortical Surface Reflecting Geometrical Properties of Sulci , 2013, PloS one.
[46] Christian Gaser,et al. Cortical thickness and central surface estimation , 2013, NeuroImage.
[47] A. Roses,et al. Longitudinal modeling of cognitive aging and the TOMM40 effect , 2012, Alzheimer's & Dementia.
[48] J. Donnelly,et al. A community-based approach to trials of aerobic exercise in aging and Alzheimer's disease. , 2012, Contemporary clinical trials.
[49] Paul K Crane,et al. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. , 2012, Archives of neurology.
[50] A. Roses,et al. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging , 2012, Alzheimer's & Dementia.
[51] Michael W. Lutz,et al. Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants , 2012, Experimental Gerontology.
[52] W. Kukull,et al. Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 , 2012, Journal of neuropathology and experimental neurology.
[53] J. Nierenberg,et al. Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants , 2012, Psychoneuroendocrinology.
[54] D. Balota,et al. Role of family history for Alzheimer biomarker abnormalities in the adult children study. , 2011, Archives of neurology.
[55] R. Swerdlow,et al. Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What , 2011, Neurotoxicity Research.
[56] David M Holtzman,et al. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. , 2011, Archives of neurology.
[57] Robert C. Green,et al. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ɛ3/ɛ3 genotype , 2011, Alzheimer's & Dementia.
[58] Paul M. Thompson,et al. Local cortical surface complexity maps from spherical harmonic reconstructions , 2011, NeuroImage.
[59] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[60] P. Thompson,et al. Algorithms to Improve the Reparameterization of Spherical Mappings of Brain Surface Meshes , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[61] Brandon Brown,et al. Fractal dimension analysis of the cortical ribbon in mild Alzheimer's disease , 2010, NeuroImage.
[62] A. Roses,et al. Genetic variation at a single locus and age of onset for Alzheimer's disease , 2010, Alzheimer's & Dementia.
[63] R. Honea,et al. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease , 2010, Neurology.
[64] A D Roses,et al. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease , 2009, The Pharmacogenomics Journal.
[65] Amity E. Green,et al. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls , 2009, Human brain mapping.
[66] Russell H. Swerdlow,et al. The Alzheimer's disease mitochondrial cascade hypothesis: An update , 2009, Experimental Neurology.
[67] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[68] Nathaniel Mercaldo,et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery , 2009, Alzheimer disease and associated disorders.
[69] Norbert Schuff,et al. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls , 2009, NeuroImage.
[70] Sang Won Seo,et al. Sulcal morphology changes and their relationship with cortical thickness and gyral white matter volume in mild cognitive impairment and Alzheimer's disease , 2008, NeuroImage.
[71] John Ashburner,et al. A fast diffeomorphic image registration algorithm , 2007, NeuroImage.
[72] Rebecca F. Halperin,et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.
[73] N. Schuff,et al. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. , 2006, Brain : a journal of neurology.
[74] Anders M. Dale,et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.
[75] J Ashburner,et al. Computational neuroanatomy: new perspectives for neuroradiology. , 2001, Revue neurologique.
[76] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[77] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .
[78] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[79] Vladimir V. Frolkis,et al. Neurobiology of Aging , 2019, Psychobiology of Behaviour.
[80] R. Swerdlow,et al. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. , 2004, Medical hypotheses.